Literature DB >> 29240636

The Etiology of Genital Ulcer Disease and Coinfections With Chlamydia trachomatis and Neisseria gonorrhoeae in Zimbabwe: Results From the Zimbabwe STI Etiology Study.

More Mungati1, Anna Machiha, Owen Mugurungi, Mufuta Tshimanga, Peter H Kilmarx, Justice Nyakura, Gerald Shambira, Vitalis Kupara, David A Lewis, Elizabeth Gonese, Beth A Tippett Barr, H Hunter Handsfield, Cornelis A Rietmeijer.   

Abstract

BACKGROUND: In many countries, sexually transmitted infections (STIs) are treated syndromically. Thus, patients diagnosed as having genital ulcer disease (GUD) in Zimbabwe receive a combination of antimicrobials to treat syphilis, chancroid, lymphogranuloma venereum (LGV), and genital herpes. Periodic studies are necessary to assess the current etiology of GUD and assure the appropriateness of current treatment guidelines.
MATERIALS AND METHODS: We selected 6 geographically diverse clinics in Zimbabwe serving high numbers of STI cases to enroll men and women with STI syndromes, including GUD. Sexually transmitted infection history and risk behavioral data were collected by questionnaire and uploaded to a Web-based database. Ulcer specimens were obtained for testing using a validated multiplex polymerase chain reaction (M-PCR) assay for Treponema pallidum (TP; primary syphilis), Haemophilus ducreyi (chancroid), LGV-associated strains of Chlamydia trachomatis, and herpes simplex virus (HSV) types 1 and 2. Blood samples were collected for testing with HIV, treponemal, and nontreponemal serologic assays.
RESULTS: Among 200 GUD patients, 77 (38.5%) were positive for HSV, 32 (16%) were positive for TP, and 2 (1%) were positive for LGV-associated strains of C trachomatis. No H ducreyi infections were detected. No organism was found in 98 (49.5%) of participants. The overall HIV positivity rate was 52.2% for all GUD patients, with higher rates among women compared with men (59.8% vs 45.2%, P < 0.05) and among patients with HSV (68.6% vs 41.8%, P < 0.0001). Among patients with GUD, 54 (27.3%) had gonorrhea and/or chlamydia infection. However, in this latter group, 66.7% of women and 70.0% of men did not have abnormal vaginal or urethral discharge on examination.
CONCLUSIONS: Herpes simplex virus is the most common cause of GUD in our survey, followed by T. pallidum. No cases of chancroid were detected. The association of HIV infections with HSV suggests high risk for cotransmission; however, some HSV ulcerations may be due to HSV reactivation among immunocompromised patients. The overall prevalence of gonorrhea and chlamydia was high among patients with GUD and most of them did not meet the criteria for concomitant syndromic management covering these infections.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29240636      PMCID: PMC5994235          DOI: 10.1097/OLQ.0000000000000694

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  16 in total

1.  Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

Authors:  C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

2.  Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.

Authors:  K A Orle; C A Gates; D H Martin; B A Body; J B Weiss
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 3.  Neonatal herpes: what have we learned.

Authors:  David W Kimberlin; Richard J Whitley
Journal:  Semin Pediatr Infect Dis       Date:  2005-01

4.  Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa.

Authors:  David A Lewis; Etienne Müller; Lisa Steele; Maya Sternberg; Frans Radebe; Michael Lyall; Ronald C Ballard; Gabriela Paz-Bailey
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

5.  Etiologic pattern of genital ulcers in Lusaka, Zambia: has chancroid been eliminated?

Authors:  Mpundu Makasa; Anne Buve; Ingvild Fossgard Sandøy
Journal:  Sex Transm Dis       Date:  2012-10       Impact factor: 2.830

Review 6.  Neonatal herpes simplex virus infections.

Authors:  R J Whitley
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

Review 7.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

Authors:  Esther E Freeman; Helen A Weiss; Judith R Glynn; Pamela L Cross; James A Whitworth; Richard J Hayes
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

8.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

9.  Epidemiology of Haemophilus ducreyi Infections.

Authors:  Camila González-Beiras; Michael Marks; Cheng Y Chen; Sally Roberts; Oriol Mitjà
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

10.  Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study.

Authors:  N Saman Wijesooriya; Roger W Rochat; Mary L Kamb; Prasad Turlapati; Marleen Temmerman; Nathalie Broutet; Lori M Newman
Journal:  Lancet Glob Health       Date:  2016-08       Impact factor: 26.763

View more
  7 in total

1.  The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study.

Authors:  Z Mike Chirenje; Nicholas Dhibi; H Hunter Handsfield; Elizabeth Gonese; Beth Tippett Barr; Lovemore Gwanzura; Ahmed S Latif; Dumisili Venessa Maseko; Ranmini S Kularatne; Mufuta Tshimanga; Peter H Kilmarx; Anna Machiha; Owen Mugurungi; Cornelis A Rietmeijer
Journal:  Sex Transm Dis       Date:  2018-06       Impact factor: 2.830

2.  Serological Markers for Syphilis Among Persons Presenting With Syndromes Associated With Sexually Transmitted Infections: Results From the Zimbabwe STI Etiology Study.

Authors:  Cornelis A Rietmeijer; More Mungati; Peter H Kilmarx; Beth Tippett Barr; Elizabeth Gonese; Ranmini S Kularatne; David A Lewis; Jeffrey D Klausner; Luanne Rodgers; H Hunter Handsfield
Journal:  Sex Transm Dis       Date:  2019-09       Impact factor: 2.830

Review 3.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 4.  Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward.

Authors:  Teodora Ec Wi; Francis J Ndowa; Cecilia Ferreyra; Cassandra Kelly-Cirino; Melanie M Taylor; Igor Toskin; James Kiarie; Nancy Santesso; Magnus Unemo
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

5.  High prevalence of sexually transmitted infections and risk factors among HIV-positive individuals in Yunnan, China.

Authors:  Wei Tu; Yu-Ye Li; Yi-Qun Kuang; Rong-Hui Xie; Xing-Qi Dong; Dan Zhang; Yan-Ling Ma; Wan-Yue Zhang; Lin Lu
Journal:  Eur J Med Res       Date:  2022-01-13       Impact factor: 2.175

6.  High Prevalence of Chlamydia and Gonorrhea and the Need for Sexually Transmitted Infection Testing Among Men Who Have Sex With Men and Transgender Women in Papua New Guinea.

Authors:  Avi J Hakim; Chelsea Iwamoto; Steven G Badman; Barne Willie; Simon Pekon; Herick Aeno; Ruthy Neo-Boli; Sophie Ase; Damian Weikum; Andrew J Vallely; Angela Kelly-Hanku
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

7.  The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study.

Authors:  Katharine Jane Looker; Christine Johnston; Nicky J Welton; Charlotte James; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily; Sami L Gottlieb
Journal:  BMJ Glob Health       Date:  2020-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.